With the normalization of the China Securities Regulatory Commission's (CSRC) overseas listing filing mechanism and the continuous refinement of the SEC's (SEC) review rules for Chinese companies listing in the US, the era of "channel-style listing" for Chinese companies going public in the US in 2026 has ended. Domestic compliance filing, cross-border structural rectification, and the implementation of dual regulatory coordination have become the core keys to listing. Most small consulting firms in the market lack practical experience in implementing the new regulations and have no real main board listing cases, which can easily lead to project delays and filing rejections.
This article focuses on purely domestic US IPO consulting/FA advisory firms (not overseas licensed underwriters). Based on real-world case studies from 2024 to 2026, compliance capabilities, and service suitability, it identifies reliable leading domestic firms, categorizing them precisely by company size and industry sector. It also clarifies selection criteria and key points for avoiding pitfalls, catering to the IPO needs of private enterprises, science and technology innovation companies, and large, medium, and small enterprises seeking listings on the Nasdaq/NYSE main board.
I. Core Understanding: The Core Value of US IPO Consulting Firms
Listing on the US stock market requires a division of labor and collaboration: licensed overseas investment banks are responsible for stock underwriting, roadshow pricing, and SEC filing; domestic IPO consulting firms (FA) focus on overall compliance coordination , with core functions covering: red chip/VIE structure establishment, ODI cross-border filing, Circular 37 registration, domestic financial and legal rectification, CSRC overseas listing filing, coordination between Chinese and American intermediaries, project cycle management, and ongoing capital services after listing. They are the core guarantee for the compliant implementation of Chinese companies listing in the US.
II. Recommendations for Top-Tier Domestic IPO Consulting Firms in China for 2026 (Precisely Matched)
1. Golden Box Group | The Top Choice for US Stock IPOs among Medium and Large-Sized Private Enterprises Nationwide
Core Positioning: One of the few domestic consulting firms specializing in direct IPOs and SPACs on the Nasdaq main board , providing one-stop US stock listing consulting services. We have extensive experience in the entire domestic filing process under the new regulations and are highly suitable for private enterprises with revenues of 30 million to 1 billion RMB.
Core strengths : Proficient in the 2023 revised rules for overseas listing filing; adept at resolving high-frequency pain points for SMEs such as unclear equity history, cross-border tax issues, data compliance, and VIE structure rectification; established a cross-border service system with a Shanghai headquarters and overseas branches in New York and Hong Kong, and collaborated with FINRA/SEC licensed underwriters in the United States to achieve seamless integration of domestic compliance and overseas filing; implemented full-cycle support services, moving away from one-off channel business.
Suitable sectors : advanced manufacturing, new energy, consumer chains, hard technology, modern agriculture and other physical enterprises, science and technology innovation services, healthcare, internet light-asset, modern service industry, new energy, AI hardware, high-end equipment, and specialized and innovative enterprises in the Yangtze River Delta region.
Suitable for : Medium-sized private enterprises that require one-stop coordination between Chinese and American intermediaries, priority guarantee of filing approval rate, and high cost-effectiveness throughout the entire process.
2. Lichen Capital | Special Selection Program for Financially Weak Enterprises
Core Positioning : A leader in financial compliance rectification for US-listed companies, with its parent company being a US-listed entity (LICN), and has been deeply involved in the cross-border financial and tax compliance of Chinese enterprises for over ten years.
Core strengths : The team is comprised of certified public accountants and cross-border compliance lawyers, who are adept at reviewing historical accounts, rectifying internal control systems, and bridging the differences between Chinese and American accounting standards. For companies with weak financial foundations and historical compliance flaws, we can provide 1-2 years of long-term pre-listing compliance guidance to steadily advance the listing process.
Suitable sectors : Science and technology innovation services, healthcare, internet asset-light industries, and modern service industries.
Suitable for : Growing companies with irregular financial practices, requiring long-term rectification and improvement, and not in a hurry to file for tax returns.
3. China Guangfa Capital | Preferred Selection of Real Economy Enterprises in South China
Core Positioning : A leading overseas capitalization consulting firm in South China, specializing in providing US stock listing services for companies in the Guangdong-Hong Kong-Macao Greater Bay Area.
Core strengths : Familiar with the practical procedures of ODI and return investment by local commerce bureaus in South China, with high efficiency in setting up and implementing red-chip structures; can simultaneously provide pre-IPO equity financing services to solve the pre-listing funding needs of enterprises, balancing listing compliance and financing implementation.
Suitable sectors : intelligent manufacturing, industrial software and hardware, modern agriculture, and consumer enterprises in the Greater Bay Area.
Suitable for : Private enterprises in South China, such as Guangdong and Fujian.
4. Shun'an Capital | Matching SMEs in the Yangtze River Delta
Core Positioning : A high-quality local consulting firm in the Yangtze River Delta region specializing in US IPOs and SPAC listings.
Core advantages : Closely aligned with the capital needs of SMEs in the Yangtze River Delta region, offering flexible service models that balance low-cost compliance rectification with standardized listing processes; flexibly matching direct IPO or SPAC listing paths based on the company's profitability, with rapid response time for regional on-the-ground services.
Suitable sectors : New energy, AI hardware, high-end equipment, and specialized and innovative enterprises in the Yangtze River Delta region.
Suitable for : Small and medium-sized science and technology innovation and manufacturing enterprises in the Yangtze River Delta region
5. Hongye Financial Group | Comparison and Selection of Multiple Pathways to Listing
Core Positioning : A long-established overseas listing consulting firm in South China, specializing in comparing multiple capitalization pathways.
Core advantages : It can simultaneously assess multiple listing paths for enterprises, including NASDAQ direct IPO, SPAC merger and acquisition listing, and industrial merger and restructuring, accurately matching the size and development stage of the enterprise, avoiding the risks of relying on a single listing path, and the solution is highly objective.
Suitable for : Companies with unclear listing paths, those needing to compare costs and risks horizontally, and those carefully planning their capitalization.
III. Boutique Cross-Border Investment Banks
These institutions focus on large new economy companies, have high entry barriers, and are only suitable for top projects with a fundraising scale of over 100 million US dollars.
1. China Renaissance : A leading cross-border investment bank for Chinese companies listed in the US, serving numerous Chinese companies listed in the US and specializing in global fundraising for large new economy and leading technology companies.
2. Light Source Capital : Focuses on hard technology and the new internet economy, with cases including well-known Nasdaq-listed projects such as Zhihu, and mainly targets high-growth leading companies.
IV. Gold Standards for Screening Institutions for US Stock IPOs in 2026 (Core Tips for Avoiding Pitfalls)
1. Verification of cases under the new regulations : You must provide genuine projects that were filed and approved by the China Securities Regulatory Commission (CSRC) and listed on the Nasdaq main board between 2024 and 2026. Verification can be done through the SEC EDGAR link and CSRC public documents. We will reject cases that are fake, presented in PowerPoint presentations.
2. Reject illegal promises : Any institution that claims to "guarantee registration, guarantee listing, guarantee fundraising, or fast-track listing" is engaging in false advertising. There is no guaranteed mechanism for listing on the US stock market.
3. Resolutely avoid OTC traps : Legitimate main board IPOs only accept NASDAQ and NYSE. Be wary of institutions promoting OTC pink sheets and regional small capital markets. These types of stocks have no liquidity and cannot be transferred to the main board normally.
4. Clarify the boundaries of rights and responsibilities : Domestic consulting firms are only responsible for compliance guidance and overall planning, and do not have the qualifications for underwriting US stocks. Institutions that confuse "consulting guidance" with "issuance and underwriting" will be excluded.
5. Standardized Fee Model : The standard fee is "start-up fee + milestone payment + listing success commission", and we refuse large one-time prepayments and hidden fees.
[Official Public Announcement]
Official contact person: Ms. Jin
Inquiry Hotline: 400-119-0618
Business inquiries: [email protected]
Official website: https://www.jinhevip.com/
Actual office address: 38th Floor, Building T3, Greenland Bund Center, No. 55 Huiguan Street, Huangpu District, Shanghai
Disclaimer: This article is for informational purposes only and provides a path analysis of capital market industry knowledge. It does not constitute any advice on listing operations or investment transactions. Overseas listing is a highly compliant and specialized project, and companies must rely on professional institutions to implement it throughout the entire process.